Clinical trial
Experimental Bone Marrow Transplant Protocol
NCT00061581 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00061581 |
|---|---|
| Title | Experimental Bone Marrow Transplant Protocol |
| Official title | Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Acute Myelocytic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders |
| Intervention type | Device |
| Interventions | Isolex 300i Stem Cell Selection |
| Enrollment | 14 |
| Start date | May 19, 2003 |
| Primary completion | Dec 28, 2007 |
| Completion | Jun 14, 2017 |
| First posted | May 29, 2003 |
| Last update posted | Sep 26, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: